NVCT
Nuvectis Pharma, Inc. · Healthcare
Chair, CEO and 10% owner Ron Bentsur bought $169K of Nuvectis Pharma, Inc.
Bought$168,725
$8.69Price
19,426Shares
+1%Stake
What NVCT did for a copier
- $1,000 copied at Mon, Aug 22 open, $8.91
- $791
- S&P 500, same days
- −9.0%
Measured over 30 trading days, to the Oct 4 close.
Ron Bentsur's record
11 other buys with 3 months of prices since 2022: on average +61.1% against the S&P 500, and 8 of 11 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Aug 18. Filed Mon, Aug 22, 5:00 AM ET, before the open. Returns use the Aug 22 open and the Oct 4 close. Not investment advice.